From MIC creep to MIC decline: Staphylococcus aureus antibiotic susceptibility evolution over the last 4 years.
暂无分享,去创建一个
J. Ruiz | P. Ramírez | M. Gordón | E. Villarreal | J Ruiz | E Villarreal | M Gordon | J Frasquet | A Castellanos | P Ramirez | J. Frasquet | Á. Castellanos
[1] P. Ward,et al. Clinical features associated with bacteremia due to heterogeneous vancomycin-intermediate Staphylococcus aureus. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[2] K. Stellrecht,et al. Correlation between Vancomycin MIC Values and Those of Other Agents against Gram-Positive Bacteria among Patients with Bloodstream Infections Caused by Methicillin-Resistant Staphylococcus aureus , 2009, Antimicrobial Agents and Chemotherapy.
[3] T. V. Van Schooneveld,et al. Association between vancomycin minimum inhibitory concentration and mortality among patients with Staphylococcus aureus bloodstream infections: a systematic review and meta-analysis. , 2014, JAMA.
[4] S. Mojal,et al. Relationship between consumption of MRSA-active antibiotics and burden of MRSA in acute care hospitals in Catalonia, Spain. , 2014, The Journal of antimicrobial chemotherapy.
[5] P. Hsueh,et al. Correlation between antimicrobial consumption and incidence of health-care-associated infections due to methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci at a university hospital in Taiwan from 2000 to 2010 , 2013, Journal of Microbiology, Immunology and Infection.